Annual Report

Overview

The report covers FY23 financial performance, geographic expansion, workforce scale and the newly introduced BRSR. It reports consolidated revenue from operations of Rs. 33,643.27 Lakhs and over 600 employees on a consolidated basis. During the year, the company expanded into Honduras, El Salvador and the Central African Republic and acquired land for its first pharmaceutical manufacturing facility. The report also presents ESG disclosures through its BRSR, although those disclosures are stated to be on a standalone basis.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: Ends 31 March 2023
Publication date: 1 August 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services